{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:00:03Z","timestamp":1762459203599},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.gene.2014.08.004","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T21:32:21Z","timestamp":1407187941000},"page":"275-279","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["An intronic haplotype in \u03b1 galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke"],"prefix":"10.1016","volume":"549","author":[{"given":"David A.","family":"Zeevi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elinor","family":"Hakam-Spector","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yair","family":"Herskovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Beeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Elstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gheona","family":"Altarescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2014.08.004_bb0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2133.1898.tb16317.x","article-title":"A case of angiokeratoma","volume":"18","author":"Anderson","year":"1898","journal-title":"Br. J. Dermatol."},{"issue":"6067","key":"10.1016\/j.gene.2014.08.004_bb0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/321209a0","article-title":"CpG-rich islands and the function of DNA methylation","volume":"321","author":"Bird","year":"1986","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.gene.2014.08.004_bb0120","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/humu.1219","article-title":"Fabry disease: 20 novel GLA mutations in 35 families","volume":"18","author":"Blaydon","year":"2001","journal-title":"Hum. Mutat."},{"issue":"20","key":"10.1016\/j.gene.2014.08.004_bb0180","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/emboj.2008.201","article-title":"An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies","volume":"27","author":"Bosnakovski","year":"2008","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.gene.2014.08.004_bb0080","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/jmg.30.8.658","article-title":"Sequence variations in the first exon of \u03b1-galactosidase A","volume":"30","author":"Davies","year":"1993","journal-title":"Med. Genet."},{"issue":"10","key":"10.1016\/j.gene.2014.08.004_bb0215","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.gene.2014.08.004_bb0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.gene.2014.08.004_bb0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population","volume":"83","author":"Dobrovolny","year":"2005","journal-title":"J. Mol. Med."},{"issue":"2","key":"10.1016\/j.gene.2014.08.004_bb0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.gene.2012.06.013","article-title":"X-inactivation in Fabry disease","volume":"505","author":"Elstein","year":"2012","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.gene.2014.08.004_bb0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.gene.2014.08.004_bb0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01986897","article-title":"Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae)","volume":"43","author":"Fabry","year":"1898","journal-title":"Arch. Dermatol. Syph."},{"issue":"11","key":"10.1016\/j.gene.2014.08.004_bb0140","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ejhg.2008.109","article-title":"Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease","volume":"16","author":"Filoni","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.gene.2014.08.004_bb0090","series-title":"Fabry Disease","first-page":"3","article-title":"Molecular genetics of Fabry disease and genotype\u2013phenotype correlation","author":"Gal","year":"2010"},{"issue":"3","key":"10.1016\/j.gene.2014.08.004_bb0100","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1006\/bbrc.1999.0310","article-title":"Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches","volume":"257","author":"Germain","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.gene.2014.08.004_bb0135","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/339431","article-title":"Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype","volume":"70","author":"Ishii","year":"2002","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.gene.2014.08.004_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ng999","article-title":"Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere","volume":"32","author":"Lemmers","year":"2002","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.gene.2014.08.004_bb0170","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1086\/521986","article-title":"Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy","volume":"81","author":"Lemmers","year":"2007","journal-title":"Am. J. Hum. Genet."},{"issue":"5999","key":"10.1016\/j.gene.2014.08.004_bb0185","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.gene.2014.08.004_bb0190","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.2454","article-title":"Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2","volume":"44","author":"Lemmers","year":"2012","journal-title":"Nat. Genet."},{"issue":"6120","key":"10.1016\/j.gene.2014.08.004_bb0210","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/327336a0","article-title":"Use of restriction enzymes to detect potential gene sequences in mammalian DNA","volume":"327","author":"Lindsay","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.gene.2014.08.004_bb0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson Fabry disease clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.gene.2014.08.004_bb0030","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate female carriers","volume":"38","author":"MacDermot","year":"2001","journal-title":"J. Med. Genet."},{"issue":"451","key":"10.1016\/j.gene.2014.08.004_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08035320600618809","article-title":"Disease manifestations and X inactivation in heterozygous females with Fabry disease","volume":"95","author":"Maier","year":"2006","journal-title":"Acta Paediatr. Suppl."},{"issue":"6","key":"10.1016\/j.gene.2014.08.004_bb0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/(SICI)1098-1004(1998)11:6<483::AID-HUMU18>3.0.CO;2-2","article-title":"Novel acceptor splice site mutation in the invariant AG of intron 6 of alpha-galactosidase A gene, causing Fabry disease. Mutations in brief no. 146. Online","volume":"11","author":"Matsumura","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2014.08.004_bb0035","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"Mehta","year":"2004","journal-title":"Eur. J. Clin. Invest."},{"issue":"Suppl. 2","key":"10.1016\/j.gene.2014.08.004_bb0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10545-008-0972-0","article-title":"The g.1170C>Tpolymorphism of the 5\u2032 untranslated region of the human alphagalactosidase gene is associated with decreased enzyme expression\u2014evidence from a family study","volume":"31","author":"Oliveira","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.gene.2014.08.004_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2261-12-39","article-title":"A classical phenotype of Anderson\u2013Fabry disease in a female patient with intronic mutations of the GLA gene: a case report","volume":"12","author":"Pisani","year":"2012","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3","key":"10.1016\/j.gene.2014.08.004_bb0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/humu.9172","article-title":"Molecular analysis in Fabry disease in Spain: fifteen novel GLA mutations and identification of a homozygous female","volume":"22","author":"Rodr\u00edguez-Mar\u00ed","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.gene.2014.08.004_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1172-8-47","article-title":"Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain","volume":"8","author":"Rombach","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"issue":"4","key":"10.1016\/j.gene.2014.08.004_bb0195","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ajhg.2013.08.004","article-title":"The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1","volume":"93","author":"Sacconi","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.gene.2014.08.004_bb0125","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0888-7543(92)90288-4","article-title":"Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5\u2032-splice site causing Fabry disease","volume":"12","author":"Sakuraba","year":"1992","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.gene.2014.08.004_bb0020","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/humu.9327","article-title":"Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease","volume":"25","author":"Sch\u00e4fer","year":"2005","journal-title":"Hum. Mutat."},{"issue":"21","key":"10.1016\/j.gene.2014.08.004_bb0045","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gene.2014.08.004_bb0200","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajhg.2012.02.019","article-title":"Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy","volume":"90","author":"Scionti","year":"2012","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.gene.2014.08.004_bb0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.20144","article-title":"Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography","volume":"25","author":"Shabbeer","year":"2005","journal-title":"Hum. Mutat."},{"issue":"5","key":"10.1016\/j.gene.2014.08.004_bb0055","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.08.010","article-title":"Prevalence of Fabry disease in stroke patients\u2014a systematic review and meta-analysis","volume":"23","author":"Shi","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.gene.2014.08.004_bb0155","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1468-1331.2010.03227.x","article-title":"Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study","volume":"18","author":"Tanislav","year":"2011","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.gene.2014.08.004_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mus.20522","article-title":"Facioscapulohumeral muscular dystrophy","volume":"34","author":"Tawil","year":"2006","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.gene.2014.08.004_bb0110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/BF03401993","article-title":"Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease","volume":"5","author":"Topaloglu","year":"1999","journal-title":"Mol. Med."},{"issue":"7","key":"10.1016\/j.gene.2014.08.004_bb0145","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2169\/internalmedicine.52.9213","article-title":"A mutant mRNA expression in an endomyocardial biopsy sample obtained from a patient with a cardiac variant of Fabry disease caused by a novel acceptor splice site mutation in the invariant AG of intron 5 of the \u03b1-galactosidase A gene","volume":"52","author":"Watanabe","year":"2013","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.gene.2014.08.004_bb0160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/ng0992-26","article-title":"Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy","volume":"2","author":"Wijmenga","year":"1992","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.gene.2014.08.004_bb0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01910542","article-title":"A 3\u2032 splice site consensus sequence mutation in the intron 3 of the alpha-galactosidase A gene in a patient with Fabry disease","volume":"36","author":"Yokoi","year":"1991","journal-title":"Jinrui Idengaku Zasshi"},{"issue":"10","key":"10.1016\/j.gene.2014.08.004_bb0060","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1373\/clinchem.2008.104711","article-title":"Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry","volume":"54","author":"Zhang","year":"2008","journal-title":"Clin. Chem."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111914009019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111914009019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T14:56:55Z","timestamp":1565708215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111914009019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0378111914009019"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2014.08.004","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An intronic haplotype in \u03b1 galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2014.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}